Advancements in sequencing technologies:
Bibliographic record
Abstract
Single-cell Sequencing (SCS) technologies, methods for analyzing genetic material at the single-cell level, offer extensive insights into cellular heterogeneity. This has broadened oncology research by enabling the exploration of functional and genetic diversity within tissues of different cell types. Furthermore, SCS facilitates the study of complex biological processes like metastasis tracking and tumor microenvironment analysis. However, the implementation of SCS methods is furrowed by a lack of clinical accessibility and high application costs. This review examines the development of SCS technologies, analyzing trends in throughput, accessibility, and cost of various commercial platforms, by focusing on the domain of cancer research and precision medicine. Despite the significant advancements offered by third-generation sequencing platforms, which provide high accuracy, versatility, and throughput for sequencing single-cell genetic information, these methods face challenges such as high error rates, insufficient funding, and complex data analysis. Furthermore, we’ve determined that the advancements of the previous decade have enabled personalized medicine and in-depth analysis of cellular heterogeneity, revolutionizing fields like medicine, biotechnology, and biological research. We anticipate our assay indicating extensive advancements in healthcare through the adoption of precision medicine concerning individual genomes and helping to demonstrate the promise of advancement in general understandings of complex biological systems. Furthermore, our research indicates that efforts to overcome technical, analytical, and cost-related challenges are essential in future clinical application, distribution, and growth of SCS methods.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.012 | 0.015 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.003 | 0.004 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.004 | 0.005 |
| Open science | 0.002 | 0.002 |
| Research integrity | 0.003 | 0.004 |
| Insufficient payload (model declined to judge) | 0.009 | 0.007 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".